Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method
Treament | Trials | |||||
---|---|---|---|---|---|---|
clinical deterioration | clinical improvement | deaths | viral clearance | |||
discontinuation of ACEI/ARB | - | - | 0.97 [0.38; 2.50], 1 RCT, I2=0% inconclusive result | - | ||
angiotensin converting enzyme inhibitors (ACEIs) | 0 | - | - | - | - | |
angiotensin receptor blockers (ARBs) | 0 | - | - | - | - | |
angiotensin-(1-7) | 0 | - | - | - | - | |
continuation of ACEI/ARB | 0 | - | - | - | - | |
RAS blocker withdrawal | 0 | - | - | - | - | |
rhACE2 | 0 | - | - | - | - |